My research spans molecular oncology and biomedical immunoengineering: therapy resistance and genome stability; solid‑tumor CAR‑T and gene/cell therapies; translational biomarkers, imaging‑based radiomics and predictive models; plus health‑economic evaluations to enable precision oncology.